1a), and all treatments lead to decreased cell viability, as measured by annexin V-PI assay (Fig
Nedelcu RI, Balaban M, Turcu G, Brinzea A, Ion DA, Antohe M, Hodorogea A, Calinescu A, Badarau AI, Popp CG, Cioplea M, Nichita L, Popescu S, Diaconu C, Bleotu C, Pirici D, Popescu R, Popescu CM, Zurac SA (2019) Efficacy of methotrexate as anti-inflammatory and anti-proliferative drug in dermatology: three case reports
Budzianowska A, Banas K, Budzianowski J, Kilowaks M
Mounjaro News & Lawsuit Updates Prior to 2025 December 2, 2024: Number of Mounjaro and GLP-1 Lawsuits Grows to 1,300 in December As of December 2, 2024, 1,300 people have alleged injuries from Mounjaro and other GLP-1 drugs and filed lawsuits as part of multidistrict litigation